Lombard Odier Asset Management (Switzerland)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-112,952
| Closed | -$4.2M | – | 395 |
|
|
2023
Q1 | $4.2M | Buy |
112,952
+42,999
| +61% | +$1.6M | 0.37% | 75 |
|
|
2022
Q4 | $3.17M | Buy |
69,953
+2,439
| +4% | +$111K | 0.25% | 89 |
|
|
2022
Q3 | $4.72M | Sell |
67,514
-8,231
| -11% | -$575K | 0.4% | 58 |
|
|
2022
Q2 | $5.09M | Buy |
75,745
+36,653
| +94% | +$2.46M | 0.43% | 59 |
|
|
2022
Q1 | $3.21M | Sell |
39,092
-82,644
| -68% | -$6.79M | 0.25% | 75 |
|
|
2021
Q4 | $17.9M | Buy |
121,736
+28,579
| +31% | +$4.19M | 1.14% | 35 |
|
|
2021
Q3 | $16.5M | Buy |
93,157
+19,447
| +26% | +$3.44M | 1.02% | 41 |
|
|
2021
Q2 | $11.9M | Buy |
73,710
+30,282
| +70% | +$4.89M | 0.6% | 65 |
|
|
2021
Q1 | $7.44M | Buy |
+43,428
| New | +$7.44M | 0.49% | 67 |
|